RXI Pharma (RXII) – Corporate News
-
Phio Pharmaceuticals Corp. (PHIO) Announces $7.7 Million Registered Direct Offering of Common Stock
-
RXI Pharma (RXII) Reports Positive Results from Phase 2 Trial with Samcyprone for Treatment of Common Warts
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to RXII Stock Lookup